Australian health technology company Cardiex has set up Conneqt, a consumer health company that will focus on home vital signs monitors, wearables and consumer health apps.

Cardiex focuses on hypertension, cardiovascular disease and vascular health disorders. Under the Conneqt brand, it says it is on track to launch multiple devices and digital products to the market over the next twelve months.

Upcoming products include the Conneqt Pulse dual blood pressure monitor anticipated to be the first consumer vital signs monitor to include central blood pressure and the company’s patented SphygmoCor technology. In addition, the company is developing a health wearable, the Conneqt Band, which includes a suite of patented health parameters as well as an ecosystem of health and wellness features focused on heart health.

“Our goal with the development of a new brand for our consumer health products was to create an emotional connection and brand recognition to compete with leaders in the field such as Fitbit, Apple, Google Health, Peloton, Whoop, Garmin and others,” said Craig Cooper, CEO of Cardiex. “We believe that Conneqt will disrupt health and fitness devices in the same way Beats disrupted Bose, Warby Parker disrupted the eyeglass industry, and Instagram disrupted photo sharing. We are uniquely positioned to be a strong market entrant into the US$100bn health wearables market given our focus on vascular and heart health – the world’s number one killer.”

Last month, Cardiex was granted another US patent for blood pressure measurement technology for non-invasive brachial blood pressure measurement, which will remain in force until 2038. The company also holds more than 14 patents in blood pressure and wearable sensor technologies which are being incorporated into the Conneqt devices.

Cardiex’s Atcor division specialises in medical devices for measuring arterial stiffness and central blood pressure waveforms based on its FDA-cleared and patented SphygmoCor technology. Under the Conneqt brand, the company is also developing consumer health wearables and devices as well as digital products.